AIBullishCrypto Briefing · Jun 77/10
🧠
University of Cambridge tests world-first AI-designed vaccine against coronaviruses
The University of Cambridge is conducting the first clinical trial of an AI-designed vaccine targeting coronaviruses, representing a breakthrough in computational drug development. This advancement could accelerate pandemic preparedness by enabling rapid vaccine design against future coronavirus variants and zoonotic spillover events.
